share_log

HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26

HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26

HC Wainwright & Co.维持对MediWound的买入,将目标价上调至26美元
Benzinga ·  2023/09/21 08:24

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MediWound (NASDAQ:MDWD) with a Buy and raises the price target from $23 to $26.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持MediWound(纳斯达克股票代码:MDWD)的买入,并将目标股价从23美元上调至26美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发